サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1247437

胸骨閉鎖システムの世界市場-2023-2030

Global Sternal Closure Systems Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
胸骨閉鎖システムの世界市場-2023-2030
出版日: 2023年03月28日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

胸骨閉鎖システムの世界市場規模は、2022年に22億9,525万米ドル、2030年には34億4,626万米ドルに達すると推定され、予測期間（2023-2030年）に5.3％のCAGRで成長します。

胸骨閉鎖システムとは、胸骨を分割して胸郭にアクセスする外科的処置である中央胸骨切りの後に、胸骨（胸骨）を閉じるために用いられる医療機器のことを指します。

これらのシステムは通常、分離した胸骨の半分をしっかりと固定するための金属板、ワイヤー、縫合糸で構成されています。創傷閉鎖システムの目的は、感染症、創傷の剥離、胸部の不安定性などの合併症を防ぐために、治癒過程で胸骨に安定性と支持を与えることです。

市場力学

胸骨閉鎖システムの世界市場の成長は、技術的進歩による心臓および胸部手術の発生率の増加、胸骨閉鎖の重要性に関する意識の高まり、人口の高齢化、医療費の増加によってもたらされます。

心臓疾患の負担増が市場成長を促進

冠動脈バイパス移植や弁置換などの心臓手術の増加により、胸骨閉鎖システムに対する需要が増加しています。

世界中で、心血管疾患（CVD）は死亡率の主要な原因となっています。虚血性心疾患（IHD）と脳卒中を中心とする心血管疾患は、身体障害者の主な原因となっています。心不全は、その有病率、死亡率、罹患率、治療による経済的負担が大きいため、ヘルスケア上の重要な課題となっています。2030年までに800万人以上のアメリカ人がHFを患うと予想されています。65歳から69歳の1,000人あたり約20人から85歳以上の1,000人あたり80人以上まで、HFの頻度は年齢とともに上昇します。HFの最も頻度の高い原因は、心臓弁膜症、高血圧、虚血性心疾患です。

また、リウマチ性心疾患（RHD）は、現在でも世界的にVHD発症の主要病因となっています。一方、先進諸国では、変性弁膜症がVHDの最も一般的な病因であると考えられています。VHDの有病率は、45歳未満の0.7%から75歳以上の13%に増加します。さらに、CVDは世界人口の50%（女性）に影響を及ぼしています。過去数十年にわたる心血管治療の著しい進歩にもかかわらず、2021年、CVDは依然として女性の罹患率と死亡率の主要な原因となっています。都市化とライフスタイルの修正が、エチオピアを含むいくつかのアフリカ諸国における心血管疾患（CVD）の発生率と有病率の上昇に寄与しており、アフリカ人は急速な疫学的変化を経験しています

胸骨閉鎖システムに伴うリスクが市場の成長を妨げる

しかし、胸骨閉鎖システムに伴うリスクは、次のとおりです。胸骨閉鎖システムは、特に切開部が適切にケアされていない場合、術後感染症のリスクを高める可能性があります。胸骨が分離し、痛み、呼吸困難、その他の合併症を引き起こす可能性のある胸骨不安定性のリスクがあります。手術中に神経が損傷し、胸や腕のしびれ、しびれ、脱力感が生じるおそれがあります。装置の誤作動により、ワイヤーの破損やその他の問題が生じ、再手術が必要になるリスクがあります。

COVID-19影響分析

COVID-19パンデミックは、胸骨閉鎖システム市場に重大な悪影響を及ぼします。2020年にInternational Journal of Surgeryに掲載された記事の通り、心臓胸部診療はCOVID-19の影響を避けられないでしょう。英国や米国では、すべての選択的・非緊急的な手術が延期され、リソースは緊急・緊急の心臓胸部サービスに振り向けられることになりました。さらに、心臓外科医はITUに移行可能な一般的なスキルを有しており、再配置の有力な候補者となっています。NHSイングランドは、COVID-19パンデミックのフェーズに基づき、心臓胸部手術の管理に関するガイダンスを発表しました。

パンデミックの期間中、選択的心臓胸部手術サービスは大幅に縮小されることになります。外科医は、電話やビデオ会議を利用して対面予約を制限し、緊急性のない紹介やフォローアップを遅らせるよう奨励されています。

2023年現在、COVID-19の状況は回復しており、すべての患者が医療施設にアクセスできるようになっています。また、心臓や胸部の手術に対する需要の増加が、世界的に市場を牽引しています。

目次

第1章 市場の手法とスコープ

  • 調査手法
  • 調査目的および調査範囲について

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 患者数の増加
      • 外科手術の件数の増加
    • 抑制要因すること：
      • 胸骨の閉鎖に伴う潜在的なリスク
    • 機会
    • 影響度分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • レギュラトリー・アナリシス

第6章 COVID-19の分析

  • 市場におけるCOVID-19の分析
    • COVID-19の市場シナリオの前に
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以降または将来シナリオ
  • COVID-19の中での価格・ダイナミクス
  • 需給スペクトル
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • 結論

第7章 製品タイプ別

  • 骨セメント
  • クロージャー装置
    • 胸部クロージャーワイヤー
    • 胸骨閉鎖用プレート・スクリュー
    • 胸部閉鎖用クリップ
    • 胸部クロージャーケーブル

第8章 手続き別

  • 中央分離帯切除術（Median Sternotomy
  • ヘミシテルノートミー
  • 両側胸部胸骨切開術

第9章 素材別

  • ステンレススチール
  • ポリエーテルエーテルケトン（PEEK）
  • チタン
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • U.K.
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢について

  • 競合シナリオ
  • 企業シェア分析
  • 製品タイプベンチマーキング
  • 主な発展と戦略

第12章 企業プロファイル

  • Depuy Synthes（Johnson & Johnson）
    • 会社概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Zimmer Biomet Holdings
  • KLS Martin Group
  • Acute Innovations
  • JACE Medical, LLC.
  • Stryker
  • Idear S.R.L
  • Praesidia SRL
  • Kinamed Incorporated
  • B. Braun

第13章 胸骨閉鎖システムの世界市場-DataM

目次
Product Code: MD1456

Market Overview

The global sternal closure systems market size was valued at US$ 2,295.25 Million in 2022 and is estimated to reach US$ 3,446.26 Million by 2030, growing at a CAGR of 5.3% during the forecast period (2023-2030).

Sternal closure systems refer to medical devices used to close the sternum (breastbone) after a median sternotomy, a surgical procedure in which the sternum is split open for access to the thorax. These systems usually consist of metallic plates, wires, or sutures used to fasten the separated halves of the sternum securely. The goal of sternal closure systems is to provide stability and support to the sternum during the healing process to prevent complications such as infection, wound separation, or instability of the chest.

Market Dynamics

The global sternal closure systems market growth is driven by technological advancements increasing incidence of cardiac and thoracic surgeries, growing awareness about the importance of sternal closure, aging population, and rise in healthcare expenditure.

An increasing burden of cardiac disorders drives the market growth

The growing number of cardiac surgeries, such as coronary artery bypass grafting and valve replacements, drives the demand for sternal closure systems. Across the world, cardiovascular disease (CVD) is the leading cause of mortality. Cardiovascular diseases, principally ischemic heart disease (IHD) and stroke, are major contributors to disability. Because of the high prevalence, mortality, morbidity, and financial burden of treating heart failure (HF), it is a significant healthcare concern. It is anticipated that more than eight million Americans will have HF by 2030. From about 20 per 1,000 people aged 65 to 69 to more than 80 per 1,000 people aged 85 and older, the frequency of HF rises with age. The most frequent causes of HF are valvular heart disease, hypertension, and ischaemic heart disease.

In addition, Rheumatic heart disease (RHD) is still a leading etiologic factor in the development of VHD worldwide. In contrast, degenerative valve disease is likely the most common etiology of VHD in developed countries. The prevalence of VHD increases from 0.7 % in people<45 years to 13 % in people over 75 years. Moreover, CVD affects 50% of the world's population (women). Despite significant progress in cardiovascular care over the past several decades, in 2021, CVD remains the major cause of morbidity and mortality for women. Urbanization and lifestyle modifications are contributing to a rise in the incidence and prevalence of cardiovascular diseases (CVDs) across several African nations, including Ethiopia, as Africans experience a rapid epidemiological transformation.

The risk associated with sternal closure systems will hamper the growth of the market

However, the risks associated with sternal closure systems. Sternal closure systems can increase the risk of postoperative infections, particularly if the incision is not properly cared for. There is a risk of sternal instability, which can cause the chest bones to separate and lead to pain, difficulty breathing, and other complications. There is a risk of nerve damage during the procedure, which can result in numbness, tingling, or weakness in the chest or arms. There is a risk of the device malfunction, which can lead to broken wires or other issues that require revision surgery. There is a risk of allergic reactions to the materials used in the sternal closure system, such as metals or adhesives.

COVID-19 Impact Analysis

The COVID-19 pandemic has profound adverse effects on the sternal closure systems market. As per the article published in the International Journal of Surgery in 2020, cardiothoracic practice will be inevitably affected by COVID-19. All elective and non-urgent procedures have been postponed in the UK and the US, with resources being redirected to the emergency and urgent cardiothoracic service. Furthermore, cardiothoracic surgeons possess generic skills which are mostly transferable to ITU, making them prime candidates for redeployment. NHS England has issued guidance on managing cardiothoracic procedures based on the phase of the COVID-19 pandemic.

The elective cardiothoracic surgery service will be greatly reduced throughout the pandemic. Surgeons are encouraged to use telephone and video conferencing to limit face-to-face appointments and to delay non-urgent referrals and follow-ups. Cardiothoracic surgeons can greatly support the ITU service, and attempts should be made to make senior staff available for redeployment.

As of 2023, the COVID-19 situation is recovering, and all patients can access healthcare facilities. In addition, increasing demand for cardiac and thoracic surgeries drives the market worldwide.

Segment Analysis

The closure devices segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The closure devices segment accounts for the highest market share. Sternal closure devices are used in cardiac surgery to securely close the sternum after a median sternotomy (an incision made down the center of the breastbone). The devices are designed to reduce the time required for sternal healing, minimize wound complications, and reduce patient discomfort compared to traditional wire cerclage methods. There has been increasing demand for sternal closure devices in recent years due to their benefits and technological advancements. Cardiac surgery procedures are becoming more prevalent due to an aging population and advancements in medical technology, leading to a growing demand for reliable and efficient sternal closure methods. Additionally, the benefits of faster recovery time and reduced patient discomfort associated with sternal closure devices have increased demand among patients and healthcare providers.

In addition, Medicon offers a titanium sternal closure system that allows stable internal fixation of the sternum after sternotomy or sternal fracture. Different titanium plates are available to suit the anatomical structures and individual clinical requirements. Also, Arthrex, Inc. offers A 100% nonmetallic, suture-based alternative to the conventional use of metal wires to bind the sternum after heart surgery, the FiberTape sternal closure system. Strong, repeatable compression from the FiberTape sternal closure implant, which is placed similarly to metal wires, aids in sternal approximation and stabilization.

Geographical Analysis

North America region holds the largest market share of the global sternal closure systems market

North America dominates the market for sternal closure systems and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of cardiac disease, and product launches by market players in the North American region drive the market.

As per the article published in the Journal of Thoracic Disease in 2022, In the U.S., thoracic surgeons can complete their training through various extremely competitive programs and are prepared to manage patients with chest problems during surgery and in the immediate aftermath. An average of 135 procedures are carried out by thoracic surgeons each year to treat conditions affecting the lungs, trachea, esophagus, chest wall, mediastinum, and diaphragm. The most frequent surgeries, usually done to treat lung cancer, are thoracoscopic surgeries with video assistance. With over 200,000 new cases anticipated this year, lung cancer is the deadliest and the second most common cancer in the U.S.

Additionally, the University of Michigan Medicine performs about 2,000 adult cardiac surgery procedures yearly using improving and cutting-edge therapies for heart and aortic illnesses.

Competitive Landscape

The sternal closure systems market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Depuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, KLS Martin Group, Acute Innovations, JACE Medical, LLC., Stryker, Idear S.R.L, Praesidia SRL, Kinamed Incorporated, and B. Braun, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the sternal closure systems market globally.

For instance,

  • In December 2020, Zimmer Biomet Holdings, Inc., acquired the Stryker Corporation, a Vance Street Capital Portfolio Company, for $150 million in cash at closing and $100 million in cash payable in 2021. Zimmer Biomet has acquired Stryker and its complete product portfolio of sternal closure devices - including cable systems, sternal sutures, and rigid fixation - along with a range of single-use complimentary temporary pacing wire and surgical punch products.

Zimmer Biomet Holdings

Overview:

Zimmer Biomet is a medical device company founded in 1927 and headquartered in the U.S. Their innovations enable the treatment of disorders of, or injuries to, joints, bones, and supporting soft tissues. Together with healthcare professionals, a company helps millions of people to live better lives.

Product Portfolio:

SternaLock XP Rigid Fixation System: The SternaLock XP Sternal Closure System is implied for stabilizing and fixing fractures of the anterior chest wall for sternal reconstructive procedures for patients with normal and poor bone.

The global sternal closure systems market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the patient population
      • 4.1.1.2. The increase in the number of surgical procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Potential Risks Associated with Sternal Closure
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bone cement*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. Closure devices
    • 7.3.1. Sternal closure wires
    • 7.3.2. Sternal closure plates and screws
    • 7.3.3. Sternal closure clips
    • 7.3.4. Sternal closure cables

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 8.1.2. Market Attractiveness Index, By Procedure
  • 8.2. Median Sternotomy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Hemisternotomy
  • 8.4. Bilateral Thoracosternotomy

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Stainless Steel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Polyether Ether Ketone (PEEK)
  • 9.4. Titanium
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Company Share Analysis
  • 11.3. Product Type Benchmarking
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Depuy Synthes (Johnson & Johnson)*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Zimmer Biomet Holdings
  • 12.3. KLS Martin Group
  • 12.4. Acute Innovations
  • 12.5. JACE Medical, LLC.
  • 12.6. Stryker
  • 12.7. Idear S.R.L
  • 12.8. Praesidia SRL
  • 12.9. Kinamed Incorporated
  • 12.10. B. Braun

LIST NOT EXHAUSTIVE

13. Global Sternal Closure Systems Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us